![Ian Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Smith
Directeur Général chez
STOKE THERAPEUTICS, INC.
Fortune : 5 M $ au 31/05/2026
Profil
Ian Frederick Smith is Chief Executive Officer & Director at Stoke Therapeutics, Inc. starting 2025.
Holds the position of Executive Chairman at Solid Biosciences, Inc. since 2022.
Chairman at iVexSol, Inc. and Rivus Pharmaceuticals, Inc. since 2023.
Director at Vertex Pharmaceuticals (Canada), Inc. and Vertex Pharmaceuticals (U.K.) Ltd. since 2011.
Independent Director at Foghorn Therapeutics, Inc. since 2021.
Director at Alkeus Pharmaceuticals, Inc. since 2022 and Areteia Therapeutics, Inc. starting 2025.
Independent Director at Odyssey Therapeutics, Inc. starting 2024.
Member of The Institute of Chartered Accountants in England & Wales, The American Institute of Certified Public Accountants, and The Financial Executives Institute.
Senior Advisor at Bain Capital Life Sciences LP.
Former Executive Chairman at ViaCyte, Inc. from 2020 to 2022.
Director at EPIX Pharmaceuticals, Inc. Former Director at Tolerx, Inc. from 2004 to 2011.
Independent Director at Acorda Therapeutics, Inc. from 2011 to 2019.
Director at Predix Pharmaceuticals, Inc. from 2005 to 2006.
Independent Director at Infinity Pharmaceuticals, Inc. from 2011 to 2019.
Director at Vertex Pharmaceuticals (Europe) Ltd. from 2011 to 2019.
Independent Director at IVERIC bio, Inc. from 2016 to 2017.
Co-Managing Director at Vertex Pharmaceuticals (Germany) GmbH.
Director at AavantiBio, Inc. Partner-Life Science & Technology Practice Group at Ernst & Young LLP from 1999 to 2001.
EVP, Chief Operating & Financial Officer at Vertex Pharmaceuticals, Inc. from 2018 to 2019.
Completed undergraduate degree at Manchester Metropolitan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/05/2026 | 246 100 ( 0,52% ) | 4 M $ | 31/05/2026 | |
| 10/06/2026 | 134 705 ( 0,14% ) | 988 735 $ | 31/05/2026 | |
| 20/04/2026 | 72 072 ( 0,12% ) | 308 468 $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Ian Smith
| Sociétés | Poste | Début |
|---|---|---|
| SOLID BIOSCIENCES INC. | Président | 16/06/2020 |
| FOGHORN THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/04/2021 |
| STOKE THERAPEUTICS, INC. | Directeur Général | 19/03/2025 |
| ODYSSEY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/08/2024 |
Rivus Pharmaceuticals, Inc.
 Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Président | 15/11/2023 |
iVexSol, Inc.
 iVexSol, Inc. Medical SpecialtiesHealth Technology Manufactures lentiviral and viral vectors | Président | 01/08/2023 |
Alkeus Pharmaceuticals, Inc.
 Alkeus Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides degenerative retinal diseases treatment services | Directeur/Membre du Conseil | 01/12/2022 |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Consultant / Advisor | - |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases | Directeur/Membre du Conseil | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Ian Smith
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Ian Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Commercial Services |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Manchester Metropolitan University
 Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Financial Executives Institute | |
Vertex Pharmaceuticals (Europe) Ltd.
 Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
Alkeus Pharmaceuticals, Inc.
Alkeus Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides degenerative retinal diseases treatment services | Health Services |
Vertex Pharmaceuticals (Canada), Inc.
Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases | Commercial Services |
Vertex Pharmaceuticals (U.K.) Ltd.
 Vertex Pharmaceuticals (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural science | Commercial Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Vertex Pharmaceuticals (Germany) GmbH
 Vertex Pharmaceuticals (Germany) GmbH Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
iVexSol, Inc.
iVexSol, Inc. Medical SpecialtiesHealth Technology Manufactures lentiviral and viral vectors | Health Technology |
Rivus Pharmaceuticals, Inc.
Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Areteia Therapeutics, Inc.
 Areteia Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
